Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly total assets is $201.06B with a quarterly period change of +0.08%. Total assets represent the full value of resources controlled by the company, including current assets, property, equipment, and intangible assets.
Reported quarterly total assets; no daily interpolation.
| Period | Total Assets | % Change |
|---|---|---|
| Quarter ended Jun 2026 | $201.06B | +0.08% |
| Quarter ended Mar 2026 | $200.89B | +0.85% |
| Quarter ended Dec 2025 | $199.21B | +3.32% |
| Quarter ended Sep 2025 | $192.82B | (0.30%) |
| Quarter ended Jun 2025 | $193.39B | (0.15%) |
| Quarter ended Mar 2025 | $193.67B | +7.53% |
| Quarter ended Dec 2024 | $180.10B | +1.02% |
| Quarter ended Sep 2024 | $178.29B | (1.55%) |
| Quarter ended Jun 2024 | $181.09B | +5.30% |
| Quarter ended Mar 2024 | $171.97B | +2.63% |
| Quarter ended Dec 2023 | $167.56B | +0.90% |
| Quarter ended Oct 2023 | $166.06B | (13.37%) |
| Quarter ended Jul 2023 | $191.69B | (2.19%) |
| Quarter ended Apr 2023 | $195.97B | +4.58% |
| Quarter ended Dec 2022 | $187.38B | +7.00% |
| Quarter ended Oct 2022 | $175.12B | (1.46%) |
| Quarter ended Jul 2022 | $177.72B | (0.35%) |
| Quarter ended Apr 2022 | $178.35B | (2.01%) |
| Quarter ended Dec 2021 | $182.02B | +1.56% |
| Quarter ended Oct 2021 | $179.23B | +1.58% |
| Quarter ended Jul 2021 | $176.44B | +2.25% |
| Quarter ended Apr 2021 | $172.56B | (1.34%) |
| Quarter ended Dec 2020 | $174.89B | +2.46% |
| Quarter ended Sep 2020 | $170.69B | +7.77% |
| Quarter ended Jun 2020 | $158.38B | +2.17% |
| Quarter ended Mar 2020 | $155.02B | (1.72%) |
| Quarter ended Dec 2019 | $157.73B | +1.42% |
| Quarter ended Sep 2019 | $155.52B | +0.26% |
| Quarter ended Jun 2019 | $155.12B | +3.39% |
| Quarter ended Mar 2019 | $150.03B | (1.91%) |
| Quarter ended Dec 2018 | $152.95B | (1.77%) |
| Quarter ended Sep 2018 | $155.70B | +0.22% |
| Quarter ended Jul 2018 | $155.37B | (0.80%) |
| Quarter ended Apr 2018 | $156.63B | (0.43%) |
| Quarter ended Dec 2017 | $157.30B | +1.06% |
| Quarter ended Oct 2017 | $155.66B | +1.87% |
| Quarter ended Jul 2017 | $152.81B | +5.44% |
| Quarter ended Apr 2017 | $144.92B | +2.63% |
| Quarter ended Dec 2016 | $141.21B | +0.60% |
| Quarter ended Oct 2016 | $140.37B | +0.40% |
| Quarter ended Jul 2016 | $139.81B | +2.63% |
| Quarter ended Apr 2016 | $136.23B | +2.11% |
| Quarter ended Dec 2015 | $133.41B | +0.11% |
| Quarter ended Sep 2015 | $133.27B | +0.93% |
| Quarter ended Jun 2015 | $132.04B | +2.68% |
| Quarter ended Mar 2015 | $128.59B | (1.36%) |
| Quarter ended Dec 2014 | $130.36B | (1.32%) |
| Quarter ended Sep 2014 | $132.10B | (2.30%) |
| Quarter ended Jun 2014 | $135.20B | +1.40% |
| Quarter ended Mar 2014 | $133.33B | +0.49% |
| Quarter ended Dec 2013 | $132.68B | +4.53% |
| Quarter ended Sep 2013 | $126.93B | +2.10% |
| Quarter ended Jun 2013 | $124.33B | +2.29% |
| Quarter ended Mar 2013 | $121.54B | +0.16% |
| Quarter ended Dec 2012 | $121.35B | +2.01% |
| Quarter ended Sep 2012 | $118.95B | +2.77% |
| Quarter ended Jul 2012 | $115.75B | (0.38%) |
| Quarter ended Apr 2012 | $116.19B | +2.24% |
| Quarter ended Dec 2011 | $113.64B | +1.63% |
| Quarter ended Oct 2011 | $111.82B | (0.26%) |
| Quarter ended Jul 2011 | $112.11B | +3.67% |
| Quarter ended Apr 2011 | $108.15B | +5.09% |
| Quarter ended Dec 2010 | $102.91B | +4.74% |
| Quarter ended Oct 2010 | $98.25B | +6.44% |
| Quarter ended Jul 2010 | $92.30B | (1.22%) |
| Quarter ended Apr 2010 | $93.44B | (1.31%) |
| Quarter ended Dec 2009 | $94.68B | +3.41% |
| Quarter ended Sep 2009 | $91.56B | +4.71% |
| Quarter ended Jun 2009 | $87.44B | +1.55% |
| Quarter ended Mar 2009 | $86.10B | +1.40% |
| Quarter ended Dec 2008 | $84.91B | (3.21%) |
| Quarter ended Sep 2008 | $87.72B | (0.44%) |
| Quarter ended Jun 2008 | $88.11B | +2.46% |
| Quarter ended Mar 2008 | $86.00B | +6.23% |
| Quarter ended Dec 2007 | $80.95B | +2.91% |
| Quarter ended Sep 2007 | $78.67B | +5.33% |
| Quarter ended Jul 2007 | $74.68B | +2.21% |
| Quarter ended Apr 2007 | $73.07B | +3.56% |
| Quarter ended Dec 2006 | $70.56B | +15.22% |
| Quarter ended Oct 2006 | $61.24B | +0.41% |
| Quarter ended Jul 2006 | $60.99B | (1.84%) |
| Quarter ended Apr 2006 | $62.13B | +5.55% |
| Quarter ended Dec 2005 | $58.86B | +4.05% |
| Quarter ended Oct 2005 | $56.57B | +3.70% |
| Quarter ended Jul 2005 | $54.55B | +0.20% |
| Quarter ended Apr 2005 | $54.45B | +2.12% |
| Quarter ended Dec 2004 | $53.32B | +2.36% |
| Quarter ended Sep 2004 | $52.09B | +3.82% |
| Quarter ended Jun 2004 | $50.17B | +2.67% |
| Quarter ended Mar 2004 | $48.87B | +1.25% |
| Quarter ended Dec 2003 | $48.26B | +3.44% |
| Quarter ended Sep 2003 | $46.66B | +2.20% |
| Quarter ended Jun 2003 | $45.65B | +8.71% |
| Quarter ended Mar 2003 | $41.99B | +3.55% |
| Quarter ended Dec 2002 | $40.56B | +4.90% |
| Quarter ended Sep 2002 | $38.66B | N/A |